The Psychology of Self Esteem is another silent movie by bigbytes. This is a para-phrasing taken from the 1969 book by Nathaniel Brandon by the same name. If you like to read or study psychology and self estemm, I recommend the book.
Open the skies over me,
I am waiting patiently,
I’ll wait for a sign.
As conspiracies unwind,
Will you slam shut,
Or free your mind,
or stay hypnotised.
And I’ve waited patiently,
And I’ll wait for the sign.
Carried through the centuries,
Secrets locked up,
And loaded on my back,
when it weighs me down.
And I am waiting patiently,
And I’ll wait for the sign. (Yeah).
And I’m waiting patiently,
I’ll wait for the sign
MORE than 1500 years after the invention of the wheelchair, there is new hope that those paralysed by everything from car accidents to sniper’s bullets can walk again, Fox News Channel reported yesterday.
The Israeli made “Rewalk” has just received US Food and Drug Administration (FDA) approval and soon will help wounded American soldiers get back on their feet.
The device is a set of mechanical legs attached to a backpack battery system that allows a paralyzed patient to “walk” all day. “I can’t believe sometime I’d walk… I can’t believe it. In dreams if I got to dream, I walked,” said Radi Kaiuf.
A sniper’s bullet paralysed him nearly 20 years ago, and doctors told him he would never walk again. Now he’s walking around and even climbing stairs.
The developers had to strike a balance between the man and the machine – the machine has to move the man, but the man has to control the machine.
It uses a simple remote control worn like a wristwatch. When the user puts it in “walk” mode and leans forward, the legs start walking. Leaning back stops the device.
It has taken nearly a decade to perfect the technology that Amit Goffer came up with in his garage, and its much more than simply a business.
“From the point of view of the disabled person it’s self esteem, the dignity of the person,” he said. “I mean sitting, being in a height of a child, a grown up in a height of a child is difficult.”
What is Watson?
Watson represents the latest in a long line of groundbreaking innovations from a company dedicated to building a Smarter Enslaved Planet. IBM Chairman and CEO Sam Palmisano explains how this technology will impact* the way humans communicate with computers in the near future. *totally dominate and suppress
IBM prepares for machine vs. man ‘Jeopardy!’ showdown
Researchers at IBM are preparing a supercomputer named Watson to compete on the popular quiz show Jeopardy! next month.
Watson has already won a practice round on the show against two top contestants, showing artificial intelligence has come a long way in simulating how humans think.
Watson, who is named after legendary International Business Machines President Thomas Watson, is a showcase of the company’s computing expertise and research in advanced science.
It also shows IBM — which turns 100 years old this year — wants to stay at the forefront of technology, even as companies such as Google Inc. and Apple Inc. have become the industry’s popular leaders.
IBM says the ability to understand language makes Watson far more evolved than Deep Blue, the company’s supercomputer which won against world chess champion Garry Kasparov in 1997.
The biggest challenge for IBM scientists was teaching Watson to differentiate between literal and metaphorical expressions and understanding puns and slang.
Feeding it knowledge was easier. Watson is not plugged into the Internet, but has a database covering a broad range of topics, including history and entertainment. – Ok this is a bit scary, imagine if it WAS hooked up to the internet!
Humans $4,600, Watson $4,400 in Jeopardy! Beta Test Round
As The Four Hundred has previously reported, IBM‘s question-answer supercomputer, known as Watson after Big Blue’s founder, Thomas Watson, is gearing up for a contest of wits against two top players of the Jeopardy! game show for three days February. To give the human contestants a chance to see what they are up against, IBM held a single round of the game at its TJ Watson Research Center last week.
Watson beats humans in Jeopardy! dry run
In a dry run that took place at a clone of the Jeopardy! game show set up at IBM’s TJ Watson Research Center, humanity didn’t do so well. (What did you expect?) In the practice round, Watson won $4,400 by stating questions, while Jennings won $3,400 and Rutter only won $1,200.
If you were betting on humanity in the upcoming grand challenge clash between humanity and IBM’s Watson question-answer (QA) supercomputer, you might want to start reconsidering your wager.
One of the things that freaked out chess champion Gary Kasparov when he initially played IBM’s Deep Blue supercomputer more than a decade ago was that he couldn’t “feel” the way the machine was thinking.
Specifically, the Watson QA software is running on 10 racks of these machines, which have a total of 2,880 Power7 cores and 15 TB of main memory spread across this system. The Watson QA system is not linked to any external data sources, but has a database of around 200 million pages of “natural language content,” which IBM says is roughly equivalent to the data stored in 1 million books. This data is stored in the main memory of the Watson machine, and the secret sauce is the software that allows Watson to listen to the statement, rummage around through its in-memory database, come up with the probable answer, hit the buzzer, and speak the question the statement answers. All in under three seconds. The Power 750 cluster is rated at 80 teraflops, which is a healthy amount of number-crunching power, but not outrageous by modern multi-petaflops standards.
To give Watson a face, IBM came up with an avatar that shows the earth and the graphical representation of IBM founder Thomas Watson’s “Think” admonition, which is the hash marks that denote a lightbulb going off. (The Watson super is named after Big Blue’s founder, and it is no accident that the Jeopardy! Grand Challenge is taking place during the company’s centennial year.) As Watson is thinking, the satellite lines on the avatar – what IBM calls “thought rays” – move faster and as the system is more confident of its answer, these lines turn green. The thought rays turn orange when Watson is wrong.
I wouldn’t bet on seeing a lot of orange thought rays in February.
IBM prepares for machine vs. man ‘Jeopardy!’ showdown
A win on the actual show, which goes on air Feb. 14, 15 and 16, would be a triumph for IBM, which spends around US$6 billion per year in research and development. An unspecified portion of that spending goes to what IBM calls “grand challenges,” or big, multi-year science projects such as Watson and Deep Blue.
See also: Joshua Blue & Diffuse Artificial Thought
Find more @ http://www.youtube.com/user/cveitch
It appears my article has spread over the internet land, too bad this guy doesn’t know what he’s talking about. Check it, he started with this article in response to my own. One month after this article, he writes another in a completely different tune. I had to have a chuckle about it.
Here is the first one:
Conspiracy Theory: How 16 Digits Linked Australian Medicare to Chip Implants
And the follow up:
Inside the Australian Government’s Scary Web Site on Microchip ID Implants
If you were wondering, my original article can be found here:
Kevin Rudd’s e-Health bill paves the way for PositiveID human implantable RFID microchips
DELRAY BEACH, Fla., Nov. 17, 2010 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or the “Company”) (Nasdaq:PSID) announced today that it has launched “The Wireless Body™” at the ID WORLD International Congress in Milan, Italy. The “Wireless Body” is an integrated, in vivo and external, smart healthcare communication system for diabetes management today and other disease management applications in the future. The “Wireless Body” is designed to enhance the management of diabetes by allowing disease management systems to communicate with each other and deliver solutions to patients seamlessly, enhancing the ability to deliver personalized medical solutions wirelessly.
Using its experience and expertise gained from developing the world’s first and only health-related implantable RFID (radio frequency identification) microchip cleared by the U.S. Food and Drug Administration, the Company has initiated the integration and development of other healthcare communication devices to communicate from within the body to outside of the body on an integrated platform: The “Wireless Body” by PositiveID. The “Wireless Body” also has the ability to identify medical devices, currently catheter ports, to allow them to communicate with PositiveID’s products to ensure proper medication dosages and safety for the patient from the port.
“We are excited to launch The Wireless Body as it expands the solutions we offer patients with diabetes to an entirely new level,” said Scott R. Silverman, Chairman and CEO of PositiveID. “Diabetes management requires an integrated solution, one that allows continuous monitoring and communication with devices that deliver solutions. We believe the ability to deliver an integrated solution wirelessly will enhance the quality of life for patients with diabetes and improve their compliance. The recent $24 million investment by Novartis into Proteus Biomedical’s ingestible wireless microchip highlights the opportunities in this sector and clearly validates the vision we began in this field over seven years ago.”
The Company’s technology has previously been used in Smart Healthcare by providing a vital electronic medical record and other wellness information to patients, caregivers and physicians. Most recently, PositiveID has evolved its implantable technology to focus on sensor applications through its GlucoChip™, a glucose-sensing microchip currently under development, and potentially other sensor applications based on its Patent No. 7,125,382 for an Embedded Bio-Sensor System. The GlucoChip is designed to communicate wirelessly to a handheld scanner outside of the body to deliver in vivo glucose readings without the need to draw blood.
Moving forward, the Company plans to integrate its wireless product portfolio with its patent-pending iglucose™ system, a wireless communication system for the transmission of glucose readings, to create automatic logs of glucose readings which can be delivered wirelessly to a third party (i.e. a caregiver or physician) from a handheld reader or traditional glucometer.
And Satan claims another soul!
PositiveID Corporation (“PositiveID”) (Nasdaq:PSID), a leader in next generation patient monitoring and diagnostics, announced today that it has added Olympian Gary Hall, Jr. as an advisor to maximize the Company’s diabetic initiatives. Hall, who has type-1 diabetes and is celebrity advocate for the Juvenile Diabetes Research Foundation (JDRF), has testified in front of Congress on current healthcare issues, campaigned for diabetes awareness, headed patient compliance efforts, patient outreach programming, education initiatives, and fundraising efforts for important diabetes research.
Internationally recognized for medaling in three Olympics, despite having diabetes, Gary Hall, Jr. is an active diabetes industry consultant with vast experience working in the healthcare industry. He is an international lecturer with a highly developed media presence and a key opinion leader on diabetes and its impact on society. A distinguished humanitarian award recipient for his outreach work achievement through national and international campaigns Gary has established vast networks in healthcare, the International Olympic movement, media, politics and industry.
Hall stated, “I am eager and excited to help PositiveID maximize the potential reach of their innovative diabetes management products. As a person living with diabetes and as an elite athlete, I know the importance of blood glucose management and awareness. The Company is taking the management of this devastating chronic illness to a new level, and together, I believe we can make important in-roads in diabetes care.”
Scott R. Silverman, Chairman and CEO of PositiveID, said, “We believe the addition of Gary Hall, Jr., one of the world’s most highly decorated and recognized Olympic athletes and a key opinion leader on diabetes issues, as an advisor for PositiveID will help us as we continue our development and prepare to bring diabetes management products to market, both from a business and a patient perspective. We will utilize Gary’s extensive knowledge about this disease and the strong contacts he has in order to establish additional beneficial relationships in the diabetes market.”